ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s Pipeline

Jul 17, 2023 ProMIS   [PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Massachusetts – July 17, 2023 – ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and…
Read More

About The Author

Jonathan Jeriah

See author's posts